Correlation Between Visa and BrightGene Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and BrightGene Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and BrightGene Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and BrightGene Bio Medical, you can compare the effects of market volatilities on Visa and BrightGene Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of BrightGene Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and BrightGene Bio.

Diversification Opportunities for Visa and BrightGene Bio

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between Visa and BrightGene is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and BrightGene Bio Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BrightGene Bio Medical and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with BrightGene Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BrightGene Bio Medical has no effect on the direction of Visa i.e., Visa and BrightGene Bio go up and down completely randomly.

Pair Corralation between Visa and BrightGene Bio

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.43 times more return on investment than BrightGene Bio. However, Visa Class A is 2.31 times less risky than BrightGene Bio. It trades about 0.37 of its potential returns per unit of risk. BrightGene Bio Medical is currently generating about 0.0 per unit of risk. If you would invest  31,531  in Visa Class A on October 30, 2024 and sell it today you would earn a total of  1,923  from holding Visa Class A or generate 6.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy90.0%
ValuesDaily Returns

Visa Class A  vs.  BrightGene Bio Medical

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
BrightGene Bio Medical 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in BrightGene Bio Medical are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, BrightGene Bio is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Visa and BrightGene Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and BrightGene Bio

The main advantage of trading using opposite Visa and BrightGene Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, BrightGene Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BrightGene Bio will offset losses from the drop in BrightGene Bio's long position.
The idea behind Visa Class A and BrightGene Bio Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments